跳转到内容

TLR9

本页使用了标题或全文手工转换
维基百科,自由的百科全书
TLR9
識別號
别名TLR9;, CD289, toll like receptor 9
外部IDOMIM605474 MGI1932389 HomoloGene68126 GeneCardsTLR9
為以下藥物的標靶
羟氯喹、​agatolimod sodium[1]
基因位置(人类
3號染色體
染色体3號染色體[2]
3號染色體
TLR9的基因位置
TLR9的基因位置
基因座3p21.2起始52,221,080 bp[2]
终止52,225,645 bp[2]
直系同源
物種人類小鼠
Entrez
Ensembl
UniProt
mRNA​序列

NM_138688
​NM_017442

NM_031178

蛋白序列

NP_059138

NP_112455

基因位置​(UCSC)Chr 3: 52.22 – 52.23 MbChr 9: 106.1 – 106.1 Mb
PubMed​查找[4][5]
維基數據
檢視/編輯人類檢視/編輯小鼠

Toll样受体9(英語:Toll-like receptor 9)是由人类基因 TLR9 编码的蛋白质[6],也被称为CD289分化簇289,cluster of differentiation 289),是Toll样受体(TLR)家族的成员。

功能

[编辑]

TLR家族的受体在病原识别与先天免疫的激活中起着基础作用。TLRs are named for the high degree of conservation in structure and function seen between mammalian TLRs and the Drosophila transmembrane protein Toll. TLRs是呈現在細胞表面和胞內間室的跨膜蛋白,用以識別病原體呈現的病原相关分子模式(Pathogen-associated molecular patterns,PAMPs),然後啟動製造先天获得性免疫所需的细胞因子的信號。 The various TLRs exhibit different patterns of expression. 这一基因通常表达于富含免疫细胞的组织,比如淋巴结骨髓等。研究指出,在小鼠和人中的TLR9受体可响应细菌DNA中的未甲基化的CpG寡脱氧核苷酸序列来激活先天免疫应答[7]

TLR9可以识别DNA分子中的未甲基化CpG序列CpG位点在脊椎动物非常稀少(~1%),但在细菌或病毒基因组中很丰富。TLR9在免疫系统的多种细胞中有表达,如B淋巴细胞单核细胞自然杀伤细胞(NK)浆细胞样树突状细胞。TLR9表达于细胞内,是核内体的组分之一,其功能为当细菌或病毒感染时结合其DNA上的富CpG基序来改变免疫系统的状态。TLR9的信号会导致细胞启动炎症反应,并分泌相关细胞因子,如I型干扰素IL-12等。

临床意义

[编辑]

There are new immunomodulatory treatments undergoing testing which involve the administration of artificial DNA oligonucleotides containing the CpG motif. CpG DNA has applications in treating allergies such as asthma,[8] immunostimulation against cancer,[9] immunostimulation against pathogens, and as adjuvants in vaccines.[10]

蛋白质相互作用

[编辑]

参考文献

[编辑]
  1. ^ 對Toll like receptor 9起作用的藥物;在維基數據上查看/編輯參考. 
  2. ^ 2.0 2.1 2.2 GRCh38: Ensembl release 89: ENSG00000239732 - Ensembl, May 2017
  3. ^ 3.0 3.1 3.2 GRCm38: Ensembl release 89: ENSMUSG00000045322 - Ensembl, May 2017
  4. ^ Human PubMed Reference:. National Center for Biotechnology Information, U.S. National Library of Medicine. 
  5. ^ Mouse PubMed Reference:. National Center for Biotechnology Information, U.S. National Library of Medicine. 
  6. ^ Du X, Poltorak A, Wei Y, Beutler B. Three novel mammalian toll-like receptors: gene structure, expression, and evolution. Eur Cytokine Netw. Dec 2000, 11 (3): 362–71. PMID 11022119. 
  7. ^ Entrez Gene: TLR9 toll-like receptor 9. 
  8. ^ Kline JN. Eat dirt: CpG DNA and immunomodulation of asthma. Proc Am Thorac Soc. July 2007, 4 (3): 283–8. PMC 2647631可免费查阅. PMID 17607014. doi:10.1513/pats.200701-019AW. 
  9. ^ Thompson JA, Kuzel T, Bukowski R, Masciari F, Schmalbach T. Phase Ib trial of a targeted TLR9 CpG immunomodulator (CPG 7909) in advanced renal cell carcinoma (RCC). Journal of Clinical Oncology, 2004 ASCO Annual Meeting Proceedings (Post-Meeting Edition). July 2004, 22 (14S) [2016-01-14]. (原始内容存档于2012-03-08). 
  10. ^ Klinman DM. Adjuvant activity of CpG oligodeoxynucleotides. Int. Rev. Immunol. 2006, 25 (3-4): 135–54. PMID 16818369. doi:10.1080/08830180600743057. 
  11. ^ Chuang TH, Ulevitch RJ. Triad3A, an E3 ubiquitin-protein ligase regulating Toll-like receptors. Nat. Immunol. May 2004, 5 (5): 495–502. PMID 15107846. doi:10.1038/ni1066. 

延伸阅读

[编辑]

外部链接

[编辑]



TLR9引用了美国国家医学图书馆提供的資料,这些資料属于公共领域